Menu

Going Deeper on DNA Amplification

Learn about the basics of PCR for DNA amplification, how DNA functions and replicates, picking the right polymerase for your application, and the experimental potential of whole-genome amplification with this eBook!

Mar 11, 2018
The Scientist Creative Services Team

DNA is the language of life, and unraveling its secrets is integral to the biological sciences. The ability to efficiently, consistently, and uniformly amplify DNA has transformed both our capacity to study cellular activity and our ability to direct cellular function. Technological progress has made available a host of amplification technologies and techniques for every research purpose. 

Download this eBook from The Scientist to learn about:
 • The basics of PCR for DNA amplification
 • How DNA functions and replicates
 • Picking the right polymerase for your application
 • The experimental potential of whole-genome amplification

This free eBook was made possible by an educational grant from GE Healthcare.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!